Rise in CAM use reflects rise in US healthcare costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

New Drugs for Osteoporosis: Comparison of the Costs and Required Returns With Those of Other Drugs Intended for Long-Term Use

By Edwards M.  

PharmacoEconomics, Vol. 15, Iss. 3, 1999-03 ,pp. : 269-278

Adis International

Access to resources Recommend Favorite

Issues in the Formulation of Drugs for Oral Use in Children: Role of Excipients

By Pawar S.   Kumar A.  

Pediatric Drugs, Vol. 4, Iss. 6, 2002-01 ,pp. : 371-379

Adis International

Access to resources Recommend Favorite

Estimating kidney function and use of oral antidiabetic drugs in elderly

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 3, 2015-06 ,pp. : 321-328

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines

By Greenberg Peter L.   Cosler Leon E.   Ferro Salvatore A.   Lyman Gary H.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 9, 2008-10 ,pp. : 942-953

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite